1. Short title This Act may be cited as the Methamphetamine Response Act of 2020 . 2. Findings Congress finds the following: (1) Methamphetamine poses a significant public health and safety threat and qualifies as an emerging drug threat, as defined in section 702 of the Office of National Drug Control Policy Reauthorization Act of 1998 ( 21 U.S.C. 1701 ). (2) Methamphetamine treatment admissions increased from 15.1 percent of all admissions in 2008 to 23.6 percent in 2017, the latest year for which data is available. (3) During the timeframe described in paragraph (2)— (A) methamphetamine-related treatment admissions among women increased from 19.2 percent of all drug-related treatment admissions to 28.3 percent; and (B) heroin use among those admitted for methamphetamine-related treatment increased from 5.3 percent to 23.6 percent. (4) By the end of 2019, methamphetamine availability, use, purity, and potency had increased nationally, as street-level prices declined. (5) Methamphetamine use is a nationwide issue. Its use remains widespread in Midwest and Western States and is becoming increasingly prevalent in Northeastern States. (6) Methamphetamine is the drug most often associated with violent crime. (7) According to the Centers for Disease Control and Prevention— (A) between 2018 and 2019, drug overdose deaths involving methamphetamine and other stimulants increased by 27 percent nationally; (B) the number of deaths described in subparagraph (A) increased in 27 of the 38 States that provide drug-specific overdose data to the Centers for Disease Control and Prevention